Pharmacodynamic Effects of Atorvastatin vs. Rosuvastatin on Platelet Reactivity

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 100 participants.

Also called NCT01567774

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 100 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT01567774
Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Italy (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT01567774. Randomized; quadruple masking; primary purpose treatment. Start 2012-04 (registry gives no type); primary completion 2014-03 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Pharmacodynamic Effects of Atorvastatin vs. Rosuvastatin on Platelet Reactivity
Acronym
PEARL
Intervention (Drug)
Atorvastatin
Intervention (Drug)
Rosuvastatin
Lead sponsor
University of Roma La Sapienza (class: other)

Record details

Record id
cardio:ct-nct01567774
Content hash
3fd219e7941f51018256e9c6fc97ae11e03b12c8c1371fe2b4a011c008387430